(20) found that Berberine inhibits the development of PLGC into malignant tumors by suppressing the HIF-1α signaling pathway, reducing the transcription and expression of genes such as VEGF, thus preventing tumor angiogenesis and disrupting the nutrient supply necessary for tumor growth and metastasis. This evidence concerns the gene HIF1A and neoplasm.